CommentSalmonella Typhi Vi polysaccharide conjugate vaccine protects infants and children against typhoid fever
References (12)
- et al.
Typhoid fever in children aged less than 5 years
Lancet
(1999) - et al.
Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan
Vaccine
(2012) - et al.
The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, Oxford, UK
Vaccine
(2017) - et al.
The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017
Lancet Infect Dis
(2019) - et al.
Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins
MBio
(2018) Typhoid vaccines: WHO position paper—March 2018
Wkly Epidemiol Rec
(2018)
There are more references available in the full text version of this article.
Cited by (2)
© 2021 Elsevier Ltd. All rights reserved.